Anaptysbio (ANAB) Tax Provisions (2018 - 2026)
Anaptysbio (ANAB) reported Tax Provisions of $40000.0 for Q1 2026, down 9.09% on a YoY basis from $44000.0 in Q1 2025, and down 50.62% quarter-over-quarter from $81000.0 in Q4 2025.
Anaptysbio (ANAB) Tax Provisions (2018 - 2026) Analysis & Trends
Anaptysbio has reported Tax Provisions for 6 years, with the latest figure at $40000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 9.09% year-over-year to $40000.0; the trailing twelve-month figure through Mar 2026 stood at $160000.0 (up 240.43% YoY), and the FY2025 full-year result was $164000.0, up 5366.67% from the prior year.
- Tax Provisions for Q1 2026 stood at $40000.0, down from $81000.0 in the prior quarter.
- The five-year high for Tax Provisions was $81000.0 in Q4 2025, with the low at -$6000.0 in Q4 2024.
- Historically, Tax Provisions has averaged $29000.0 across 4 years, with a median of $39000.0 in 2025.
- Annual changes were most pronounced in 2024 — Tax Provisions sank 50.0% — and 2025, when it soared 1450.0%.
- Anaptysbio's Tax Provisions stood at -$4000.0 in 2023, then slumped by 50.0% to -$6000.0 in 2024, then soared by 1450.0% to $81000.0 in 2025, then tumbled by 50.62% to $40000.0 in 2026.
- The last three Tax Provisions figures came in at $40000.0 (Q1 2026), $81000.0 (Q4 2025), and $39000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Anaptysbio | 1.66 Bn | 1.38 Bn | - | 40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40,000.00 |
| Dec 31, 2025 | 81,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | -6,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Dec 31, 2019 | -22,000.00 |
| Sep 30, 2019 | -51,000.00 |
| Jun 30, 2019 | -60,000.00 |
| Mar 31, 2019 | -19,000.00 |
| Dec 31, 2018 | -192,000.00 |